Target intelligence / Profile preview

Novel transcript, antisense to CCDC33

Molecular classification: Other, long non-coding RNA, antisense RNA

Overview

ENSG00000308463, listed as 'novel transcript, antisense to CCDC33,' is a long non-coding RNA identified in transcriptomic annotations that is transcribed antisense to the CCDC33 gene. Its presence is noted only as a sequence feature; no protein product, molecular function, or disease association has been established. It is not considered a therapeutic target and has no described applications as a biomarker or drug target.

Other names: ENSG00000308463novel transcript, antisense to CCDC33

Mechanism of action

None. There are no drugs targeting this transcript, and its function is uncharacterized.

Biological functions

UnknownCould potentially regulate CCDC33 expression at the RNA level

Disease associations

None established for this transcript

Beyond the preview

Go deeper on Novel transcript, antisense to CCDC33.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to CCDC33.

Explore the full profile